Q2BI is a biometrical and clinical science contract research organization (CRO) for the life science industry product/drug development and regulatory submissions. Founded in 2009, Q2BI has a broad range of expertise-based services in the areas of Electronic Data Capture (EDC), Clinical Data Management (CDM), Medical Services (Medical Writing, Medical Monitoring, Medical Coding), Statistical Programming, Biostatistical science, Safety Monitoring including IDMC/DSMB, Pharmacokinetics / Pharmacodynamics (PK/PD), Data Science including data visualization/analytics and System Validation Consulting. Q2BI is a pioneer in adopting CDISC and supported the world’s first FDA Project ORBIS.

AdhereTech is transforming clinical trial adherence with the Aidia System, an innovative overcap smart device that delivers real-time data without requiring apps, Wi-Fi, or syncing. Unlike traditional methods such as pill counting, journals, or video capture, Aidia provides precise, timestamped adherence tracking while placing virtually no burden on patients or sites. Patients use the Aidia-enabled bottle just like any standard medication bottle, with no change to their routine. The device connects automatically via cellular signal, is fully reusable, and requires no additional stability testing. Clinical teams benefit from customizable alerts, remote reprogramming, and proactive support from AdhereTech’s live monitoring team. By ensuring consistent dosing behavior, Aidia helps sponsors strengthen efficacy signals, maintain regulatory compliance, and avoid costly setbacks due to non-adherence. Learn more at https://adheretech.com. 

EMIT Imaging offers Cryo-Fluorescence Tomography (CFT) instrumentation and services, enabling a transformative 3D approach to analyze whole-animal therapeutic distribution and protein expression. Our imaging platform, XerraTM, provides high resolution and sensitivity imaging for improved visualization of multiplexed whole-body distribution and delivery, co-localization of drug with targets, and on/off target tissue identification. For more information, contact https://emitimaging.com/.

Stratacuity is a trusted boutique biotech staffing agency, founded in 2001, with a mission to drive groundbreaking scientific advancements. Our experienced scientific recruiters have a strong history of successfully placing exceptional talent at prominent life sciences companies in Boston and beyond. From assisting with critical initial hires through executive search, we are committed to supporting your success. Proven Scientific Placement

For more information, please visit https://www.stratacuity.com/

Image Analysis Group is a leading imaging Clinical Research Organization, combining medical expertise, a global team and the DYNAMIKA platform with embedded AI capabilities for data management and central review. For nearly 20 years, IAG supports pharma companies in developing novel drugs, using imaging to assess safety and efficacy. For more information, visit https://www.ia-grp.com/about-us/

In addition to developing demonstration devices and training materials that go beyond just informing to truly educating, Artcraft Health has launched a proprietary technology that helps ensure successful patient onboarding. DemoX™ is an electromechanical autoinjector training device that is designed to deliver a no-fail training experience. It delivers five times as many demo cycles (at least 1,000) as traditional training devices, so clinicians can be better equipped to provide the training their patients need and set them on the right path from the start.

Expand your design possibilities with Celanese engineered materials and support from in-house technical experts. Our high-performance polymers and thermoplastics unlock opportunities for improving patient care with cutting-edge medical and pharmaceutical solutions. Applications include drug delivery, long-acting controlled release delivery, medical devices, orthopedics, advanced surgical instruments, connected devices and more. To learn more, visit http://www.celanese.com/

Elcam Drug Delivery Devices (E3D™) is a subsidiary of Elcam Medical™, an Israel-based group with 40 years of experience in the development, manufacturing and global distribution of medical devices. E3D is focused on the design, development, manufacturing and supply of injectable drug delivery devices for self-administration and use in non-clinical environments. Its broad technology portfolio encompasses devices suitable for drugs in a range of primary containers – including auto-injectors, on-body delivery systems, and smart devices with wireless connectivity.

Govig Life Sciences Division’s expertise spans all multiple segments of life sciences, including Biotech, Pharma, Medical Devices, Diagnostics, Digital Therapeutics, Wearables, Radiopharmaceuticals, and other emerging service and product sectors. Through our expertise and successful placement activity, we help build your organization by addressing your needs now and throughout its life cycle. Emerging and midsized clients repeatedly retain us when they face tight timelines, knowledge and network gaps, resource constraints, or challenges related to scope and reputation. We put our tenure, relationships, and expertise to work so you can meet your deadlines, keep your promises to patients and investors, and build a successful organization. Learn more at https://govig.com/industry/life-sciences/

EmVenio Clinical Research, a Professional Case Management subsidiary, operates from U.S. and European headquarters with a team of approximately 5,000 professionals supporting clinical trials across more than 80 countries. Our community-based sites and mobile research services expand access for trial participants, while enabling sponsors and CROs to execute high-quality studies at speed and scale with clean, reliable data and consistent results. By bringing trials directly to patients in their homes, communities or places they gather, we enroll populations others miss, helping create a complete and more inclusive picture of human health. Our approach is grounded in empathy, expertise and close collaboration—bridging the gap between science and the people it serves because true progress only happens when research reflects the real world. For more information, please visit emvenio.com.

Origins is the global patient focused specialist consultancy that provides industry-leading insights and strategic counsel for our clients at critical decision points in drug development and commercialisation. To learn more, please visit www.origins-patients.com

NeoGenomics specializes in premier cancer solutions. We partner with pharmaceutical clients from discovery to commercialization with our broad oncology testing capabilities powered by in-house scientific expertise and dedicated project support teams. Our clients benefit from our state-of-the-art molecular technology, from whole exome sequencing, whole transcriptome sequencing, HLA typing, and the proprietary MultiOmyx™ high-order multiplexing methodology. We are the trusted experts with over 20 years of experience helping navigate the increasingly complex cancer landscape. For more information, visit https://neogenomics.com.